Immunogen, Inc.
IMGN
Revenue
9.29M
▲9.29M∞%
3 Months ChangeAssets
822.10M
▲107.77M▲15.09%
3 Months ChangeLiabilities
260.51M
▲37.02M▲16.56%
3 Months ChangeFree Cash Flow
-73.93M
▼-32.22M▼-77.25%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-02-12
Form 8-K
ID: 0001104659-24-013712
2024-02-08
Form 8-K
ID: 0001104659-24-011926
2024-01-31
Form 8-K
ID: 0001104659-24-008800
2024-01-29
Form 8-K
ID: 0001104659-24-007784
2024-01-24
Form 8-K
ID: 0001104659-24-006287
2024-01-08
Form 8-K
ID: 0001104659-24-002242
2023-11-30
Form 8-K
ID: 0001104659-23-122415
2023-11-02
Form 10-Q
ID: 0001558370-23-017411
2023-11-02
Form 8-K
ID: 0001558370-23-017308
2023-09-18
Form 8-K
ID: 0001558370-23-015834